The impact of atherothrombotic events on resource use and cost in patients with peripheral arterial disease

被引：0
|
作者：
Caro, J
Migliaccio-Walle, K
Ishak, K
O'Brien, JA
机构：
[1] Caro Res Inst, Concord, MA USA
[2] Caro Res Inst, Dorval, PQ, Canada
来源：
VALUE IN HEALTH | 2003年 / 6卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)64141-1
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：316 / 316
页数：1
相关论文
共 50 条
  • [1] Pharmacological prevention of atherothrombotic events in patients with peripheral arterial disease
    Blinc, A.
    Poredos, P.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2007, 37 (03) : 157 - 164
  • [2] Preventing atherothrombotic events in peripheral arterial disease: the use of antiplatelet therapy
    Hiatt, WR
    JOURNAL OF INTERNAL MEDICINE, 2002, 251 (03) : 193 - 206
  • [3] Peripheral arterial disease Atherothrombotic risk associated with peripheral arterial disease New developments in the management of atherothrombotic risk associated with peripheral arterial disease
    Cacoub, P.
    Clement, D.
    Wahlberg, E.
    Geroulakos, G.
    Henry, M.
    Klonaris, C.
    Pipinos, H.
    Vanhandenhove, I.
    Bleyn, J.
    Mooschou, M.
    Bairaktari, A.
    Allaert, F.
    PHLEBOLYMPHOLOGY, 2009, 16 (01) : 193 - 202
  • [4] Residual thrombin generation potential is inversely linked to the occurrence of atherothrombotic events in patients with peripheral arterial disease
    Gremmel, Thomas
    Koppensteiner, Renate
    Ay, Cihan
    Panzer, Simon
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2014, 44 (03) : 319 - 324
  • [5] Healthcare resource utilization and costs of major atherothrombotic vascular events among patients with peripheral artery disease after revascularization
    Desai, Urvi
    Kharat, Akshay
    Hess, Connie N.
    Milentijevic, Dejan
    Laliberte, Francois
    Zuckerman, Peter
    Benson, John
    Lefebvre, Patrick
    Hiatt, William R.
    Bonaca, Marc P.
    JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 402 - 409
  • [6] Peripheral arterial disease: prognostic significance and prevention of atherothrombotic complications
    Norman, PE
    Eikelboom, JW
    Hankey, GJ
    MEDICAL JOURNAL OF AUSTRALIA, 2004, 181 (03) : 150 - 154
  • [7] Statin use in patients with peripheral arterial disease
    Harris, Sheena K.
    Roos, Matt G.
    Landry, Gregory J.
    JOURNAL OF VASCULAR SURGERY, 2016, 64 (06) : 1881 - 1888
  • [8] Cost of atherothrombotic diseases-myocardial infarction, ischaemic stroke and peripheral arterial occlusive disease-in Germany
    Bruggenjurgen, B.
    Rupprecht, H. -J.
    Willich, S. N.
    Spannagl, M.
    Ehlken, B.
    Smala, A.
    Berger, K.
    Diener, H. C.
    JOURNAL OF PUBLIC HEALTH-HEIDELBERG, 2005, 13 (04): : 216 - 224
  • [9] Incidence of Major Atherothrombotic Vascular Events among Patients with Peripheral Artery Disease after Revascularization
    Desai, Urvi
    Kharat, Akshay
    Hess, Connie N.
    Milenthevic, Dejan
    Laliberte, Francois
    Zuckerman, Peter
    Benson, John
    Lefebvre, Patrick
    Hiatt, William R.
    Bonaca, Marc P.
    ANNALS OF VASCULAR SURGERY, 2021, 75 : 217 - 226
  • [10] Medical Therapy for Secondary Prevention of Atherothrombotic Events in Peripheral Artery Disease
    Morrison, Justin T.
    Hsia, Judith
    Bonaca, Marc P.
    HEART INTERNATIONAL, 2021, 15 (01): : 14 - 19
12345